Emerging treatment options for ovarian cancer: focus on rucaparib

Mariappan, L; Jiang, XY; Jackson, J; Drew, Y

Drew, Y (reprint author), Newcastle Univ, Northern Inst Canc Res, Paul OGorman Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.

INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2017; 9 ( ): 913

Abstract

Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) are an exciting class of anticancer drugs, which have revolutionized the management of BRCA muta......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索